Nutritional supplements, COX-2 and IGF-1 expression in men on active surveillance for prostate cancer.

Prostate cancer affects many men in the United States every year. It's one of the most common cancers among American men after skin cancer that doesn't spread (non-melanoma). In fact, back in 2009 alone, there were around 192,000 new cases and sadly about 27,000 deaths. What makes this disease tricky is how different it can be from one person to another-it's not the same for everyone. Scientists have been trying to understand more about prostate cancer by looking at what might cause or influence its development and spread in men who are diagnosed with localized (confined within the prostate) disease, which is where most cases of this type occur when they're first found. They focused on a protein called PSA that can be elevated even before symptoms appear-it’s like an early warning signal for doctors to check further into possible cancer issues in men with higher levels than normal.

This research paper delves into an investigation concerning prostate cancer (PCa), which is recognized as the most prevalent malignancy among U.S. men aside from non-melanoma skin cancers [1]. The study acknowledges that PCa exhibits significant heterogeneity in its natural history, a complexity not entirely understood within scientific communities. The researchers employed an experimental design wherein 90% of the participants had local/regional stage prostate cancer diagnoses and were indicated for biopsy due to elevated PSA levels [2]. The study's methodology involved administering a supplement or placebo, with variations based on tomato intake (high vs. low) and fish oil consumption (supplemented versus not). The primary focus of the research was examining changes in gene expression related to IGF-1 signaling pathways before and after intervention [3]. The study also considered potential post-transcriptional effects on these genes, as well as antioxidant impacts from lycopene or fish oil supplementation.